- The trend backdrop is active with a 12-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
KIMS
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Krishna Institute of Medical Sciences Limited · Healthcare · Medical Care Facilities
Latest close
811.1 INR
0.8%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 13.1% above the Trend Line and sits at 83.4% of its 52-week range. The latest completed week returned 0.8%, after a -0.5% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers. The latest news-sentiment score is 42/100.
Setup score
73
out of 100
Latest Close
811.1 INR
7 Aug 2026
1W Return
0.8%
latest completed week
4W Return
-0.5%
short-term follow-through
12W Return
6.5%
quarterly tape
Trend Breadth
50.0%
26 of 52 weeks active
Volume Ratio
2.2x
vs 13-week average
- 16 reversal markers appear in the recent smart-money tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
0.8%
Latest completed week; four-week move -0.5%.
Indicator stack
69/68
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 56.73%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
42/100
8 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 13.1% above the Trend Line and sits at 83.4% of its 52-week range. The latest completed week returned 0.8%, after a -0.5% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.2x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.9812-week average 0.73
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.98Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers1616 reversal markers
No recent accumulation markers. 16 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -0.5% over four weeks, 6.5% over 12 weeks, and 14.0% over one year. The current trend has remained active for 12 consecutive weeks.
Performance by holding period
Active trend streak12 weeks
Active weeks in one year26
Trend breadth50.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.08Latest activity-pressure read.
Pressure change-22.9%Four-week change in activity pressure.
Leadership14.96Latest relative-leadership reading.
RS change-17.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 88%
Model confidence 82%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength10/100Blend of value, momentum, and quality. Underlying universe rank 91; rank 1 is best.
Value2/100Relative valuation strength. Underlying universe rank 99; rank 1 is best.
Quality31/100Profitability and accounting quality. Underlying universe rank 70; rank 1 is best.
Momentum77/100Medium-term price momentum. Underlying universe rank 24; rank 1 is best.
Growth38/100Revenue and earnings growth. Underlying universe rank 63; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework6/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 134.4x Price divided by trailing earnings.
- Price / sales
- 8.3x Market value relative to trailing revenue.
- EV / EBITDA
- 45.1x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -2.5% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 70.8% Gross profit retained from each unit of revenue.
- Operating margin
- 13.3% Operating profit retained from revenue.
- Free-cash-flow margin
- -23.5% Free cash flow generated from revenue.
- Return on invested capital
- 6.0% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 28.9% Latest one-year revenue growth.
- EPS growth
- -37.2% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 4/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- -0.1% Net share repurchases relative to market value.
- Shareholder yield
- -0.1% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 5.1x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment42/100
Weighted news tone is negative across 8 relevant articles.
1 positive · 6 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-5.5%Distance below the 52-week high.
13-week volatility3.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher15 of 2611 weeks finished lower.
Best week+15.5%Week of 13 Feb.
Worst week-11.9%Week of 13 Mar.
Latest week+0.8%Week of 7 Aug.
Shape of recent returns
Strong gains6
Modest gains9
Flat weeks0
Modest losses8
Sharp losses3
Recent vol3.0%13-week weekly-return volatility.
Base vol4.3%52-week weekly-return volatility.
Up/down split27/24Count of positive and negative weeks in the 52-week window.
Average skew3.4% / -3.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Healthcare
4-week rank55 / 100
Group average1.2%
Trend breadth83.0%
Trend83.0%active weekly trend signals
MD85.0%positive activity pressure
RS73.0%positive relative leadership
Four-week leaders
IndustryIN Medical Care Facilities
4-week rank17 / 21
Group average2.1%
Trend breadth85.7%
Trend85.7%active weekly trend signals
MD76.2%positive activity pressure
RS61.9%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape74/100
Trend, activity pressure, participation, and risk combine to a 74/100 tape read.
Indicator analysis83/100Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.
Activity pressure 0.98; 16 reversal markers Next-Week ExpectancyPositive 56.73%Next-week expectancy is positive with a 56.73% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors27/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 77 SVQF6/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 1481.5 of 1576 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment42/100Weighted news tone is negative across 8 relevant articles.
Krishna Institute of Medical Sciences Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 811.1 INR | 0.8% | 716.9 INR | 573.5 INR | 1.08 | 14.96 | 4.9M | On |
| 31 Jul 2026 | 804.7 INR | 0.9% | 710.5 INR | 570.7 INR | 1.21 | 15.23 | 2.9M | On |
| 24 Jul 2026 | 797.8 INR | -0.6% | 704.7 INR | 567.9 INR | 1.28 | 17.38 | 2.8M | On |
| 17 Jul 2026 | 803.0 INR | -1.5% | 699.0 INR | 565.3 INR | 1.34 | 15.60 | 2.0M | On |
| 10 Jul 2026 | 814.9 INR | -4.2% | 693.6 INR | 562.6 INR | 1.40 | 18.14 | 2.6M | On |
| 3 Jul 2026 | 850.7 INR | 7.0% | 688.5 INR | 559.8 INR | 1.29 | 23.45 | 561.2K | On |
| 26 Jun 2026 | 795.3 INR | -1.1% | 683.6 INR | 556.7 INR | 1.26 | 17.10 | 0 | On |
| 19 Jun 2026 | 804.2 INR | 2.4% | 679.9 INR | 553.8 INR | 1.22 | 19.21 | 761.2K | On |
| 12 Jun 2026 | 785.1 INR | -0.5% | 675.4 INR | 551.0 INR | 1.20 | 18.97 | 483.3K | On |
| 5 Jun 2026 | 789.0 INR | 4.0% | 671.4 INR | 548.0 INR | 1.35 | 21.34 | 2.2M | On |
| 29 May 2026 | 758.8 INR | -0.7% | 669.4 INR | 545.0 INR | 1.28 | 16.40 | 1.2M | On |
| 22 May 2026 | 764.1 INR | 0.3% | 668.2 INR | 542.1 INR | 1.12 | 16.73 | 2.1M | On |
| 15 May 2026 | 761.7 INR | 6.1% | 666.7 INR | 539.3 INR | 0.93 | 17.15 | 6.2M | Off |
| 8 May 2026 | 717.6 INR | 7.6% | 665.3 INR | 536.4 INR | 0.62 | 8.45 | 2.3M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.